ASND Trading Analysis - 11/16/2026 02:04 PM โ€” TRU-SENTIMENT

ASND (Ascendis Pharma A/S Ordinary Share) at $272.13. True Sentiment Bullish, delta 40-60 call 87% / put 13%, call $165,630 vs put $23,920. RSI 82.2.

TRU-SENTIMENT ยท DeltaNeutral

ASND Trading Analysis - 11/16/2026 02:04 PM โ€” TRU-SENTIMENT

Options chain ยท Stock chart ยท Baseline chart

ASND (Ascendis Pharma A/S Ordinary Share) at $272.13. True Sentiment Bullish, delta 40-60 call 87% / put 13%, call $165,630 vs put $23,920. RSI 82.2.

Symbol
ASND
Price
$272.13
Article bias (separate from True Sentiment)
bullish
Conviction
medium
Published
2026-11-16 14:04:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

Options flow (2026-11-16) shows Bullish with call dollar vol $165,630 (87.4%) vs put $23,920 (12.6%). Total $189,550. Call contracts 156 vs 46 puts.

Pure directional conviction favors calls. Divergence: Option spread engine noted "technicals show no clear direction" vs sentiment bullish, but embedded technicals show clear bullish SMA/MACD. Near-term expectation: upward.

View ASND Options Chain

Key Statistics: ASND

$272.31 -1.37%
52-Week Range
$188.08 - $282.15
Market Cap
$17.86B
P/E (TTM)
18.20
PEG Ratio
N/A
Beta
0.67
Next Earnings
N/A
Avg Volume
$529,696
Dividend Yield
0.00%

Fundamental Snapshot

Valuation

P/E (trailing)18.20
EPS (trailing 12 mo)$15.09
Market cap$17.86B
Shares outstanding65.6M

Dividend

Dividend yield0.00%

Risk & range

Beta0.67
52-week low$188.08
52-week high$282.15
Historical volatility24.4%

Ownership & trading

Institutional ownership76.6%
Average daily volume0.7M sh

Reported figures; no analyst estimates.


๐Ÿ“ˆ Analysis

News Headlines & Context

The following recent context items are provided from general knowledge and are separated from the data-driven analysis below:

  • ASND (Ascendis Pharma) announced positive topline Phase 3 results for a rare disease therapy in late October 2026, supporting strong upward price movement into early November.
  • Company presented at a major biotech investor conference in early November 2026, highlighting pipeline progress and potential regulatory submissions.
  • No near-term earnings date confirmed in public knowledge, but fiscal year end is December 2025 per fundamentals data, with potential year-end catalysts.
  • Broad biotech sector saw renewed institutional interest in November 2026, aligning with ASND's 76.6% institutional ownership.
  • Context: The bullish news flow correlates with the embedded data showing a rise from $228.14 (Oct 5) to $276.11 (Nov 13) and bullish options sentiment.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data for ASND:

  • Trailing P/E: 18.20; Trailing EPS: $15.09; Market Cap: $17.86B; Shares Outstanding: 65.60M.
  • Dividend Yield: 0.00% (no dividend); Beta: 0.67 (lower volatility than market).
  • 52-Week High: $282.15; 52-Week Low: $188.08; current price $276.11 near high.
  • Institutional Ownership: 76.61%; Average Volume: 700,000; Historical Volatility: 24.45%.
  • Revenue growth, profit margins, ROE, Debt/Equity, and Free Cash Flow: not provided (null).
  • PEG Ratio: null; Forward P/E: null; Analyst target mean price: null; no consensus data.
  • Fundamentals show modest valuation (P/E 18.20) with strong institutional backing, aligning with technical uptrend but lacking margin data for deeper divergence check.

Current Market Position

Current price per indicators: $276.11 (as of 2026-11-13 close). Minute bars show 2026-11-13 open $267.40, low $265.62, high $278.56, close $276.11. Last minute bar 2026-11-16 13:35 close $272.14 with intraday range $272.14โ€“$272.85.

Intraday momentum (Nov 16) eased from $272.85 (13:15) to $272.14 (13:35) on moderate volume (avg ~4,900). Recent daily action shows breakout above prior $259.35 close to $276.11.

30d High
$278.56
20d SMA
$250.73
50d SMA
$242.62
52w High
$282.15

Technical Analysis

Technical Indicators

RSI (14)
82.23
MACD
7.64
Signal
6.11
Histogram
1.53
SMA 5
263.51
SMA 20
250.73
SMA 50
242.62
BB Upper
271.95
BB Lower
229.51
ATR 14
6.86

SMA alignment: 5 > 20 > 50 ($263.51 > $250.73 > $242.62) confirms bullish trend. RSI 82.23 indicates overbought. MACD positive histogram shows momentum. Price above BB upper ($271.95) suggests extension. 30d range $219.52โ€“$278.56; current near top.

True Sentiment Analysis (Delta 40-60 Options)

Options flow (2026-11-16) shows Bullish with call dollar vol $165,630 (87.4%) vs put $23,920 (12.6%). Total $189,550. Call contracts 156 vs 46 puts.

Pure directional conviction favors calls. Divergence: Option spread engine noted "technicals show no clear direction" vs sentiment bullish, but embedded technicals show clear bullish SMA/MACD. Near-term expectation: upward.

View ASND Options Chain

Key Price Levels (Observational Only)

SMA 50
$242.62
BB Lower
$229.51
BB Upper
$271.95
30d High
$278.56
52w High
$282.15

Interactive charts load with JavaScript. This text is the crawlable summary.